SB 1156·MO·senate
Enacts provisions relating to insurance coverage for prescription insulin drugs
FailedFiled Dec 1, 2025
Sponsor: Maggie Nurrenbern (D)
Latest Action
Second Read and Referred S Insurance and Banking Committee
Jan 15, 2026
Summary
The bill would stop health plans from charging members more than $30 for a 30‑day supply of prescription insulin. It also requires insurers to calculate that cost after subtracting at least all rebates they receive, while keeping rebate amounts confidential. The rule would take effect for plans starting on or after Jan. 1, 2027.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 1156 changes status, plus AI-powered summaries and stage predictions.
Sign up free